Get it on Google Play

FDA accepts United Therapeutics NDA for ralinepag PAH treatment

August 24, 2026 7:01 AM EDT Send to a Friend
United Therapeutics Corporation (Nasdaq: UTHR) announced that the U.S. Food and Drug Administration has accepted its New Drug Application for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login